Article Text

other Versions

PDF
Impact of post-colposcopy management on women's long-term worries: results from the UK population-based TOMBOLA trial
  1. Linda Sharp1,
  2. Seonaidh Cotton2,
  3. Margaret Cruickshank2,
  4. Nicola Gray3,
  5. Louise Smart4,
  6. David Whynes5,
  7. Julian Little6
  8. on behalf of the TOMBOLA Group
    1. 1Adjunct Professor, National Cancer Registry Ireland, Cork Airport Business Park, Cork, Ireland
    2. 2Trials Manager (SC) & Professor of Obstetrics & Gynaecology (MC), Department of Obstetrics & Gynaecology, University of Aberdeen, Aberdeen, UK
    3. 3Research Fellow, Centre for Academic Primary Care, University of Aberdeen, Aberdeen, UK
    4. 4Consultant Cytopathologist, Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, UK
    5. 5Professor of Health Economics, School of Economics, University of Nottingham, University Park, Nottingham, UK
    6. 6Canada Research Chair in Human Genome Epidemiology, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada
    1. Correspondence to Professor Linda Sharp, Institute of Health & Society, Newcastle University, Baddiley-Clark Building, Richardson Road, Newcastle upon Tyne NE2 4AX, UK; linda.sharp{at}ncl.ac.uk

    Abstract

    Background Effective cervical screening reduces cancer incidence and mortality. However, these benefits may be accompanied by some harms, potentially including, adverse psychological impacts. Studies suggest women may have concerns about various specific issues, such as cervical cancer.

    Aim To compare worries about cervical cancer, future fertility, having sex, and general health between women managed by alternative policies at colposcopy.

    Design Multicentre individually-randomised controlled trial, nested within the National Health Service Cervical Screening Programmes.

    Setting UK.

    Methods 1515 women, aged 20–59 years, with low-grade cytology who attended colposcopy during February 2001–October 2002, were randomised to immediate loop excision or punch biopsies with recall for treatment if cervical intraepithelial neoplasia (CIN)2/3 was confirmed. Women completed questionnaires at recruitment and after 12, 18, 24 and 30 months. Outcomes were prevalence of worries at each time-point (point prevalence) and at any time-point during follow-up (12–30 months; cumulative prevalence). Primary analysis was by intention-to-treat (ITT); secondary per-protocol analysis compared groups according to management received among women with an abnormal transformation zone.

    Results Cumulative prevalence of worries was: cervical cancer 40%; having sex 26%, future fertility 24%, and general health 60%. In ITT analyses, there were no statistically significant differences between management arms in cumulative or point prevalence of any of the worries. In per-protocol analyses, between-group differences were significant only for future fertility; cumulative prevalence was highest in women who underwent punch biopsies and treatment.

    Conclusions There is no difference in the prevalence of specific worries in women randomised to alternative post-colposcopy management policies.

    Clinical trial registration ISRCTN:34841617.

    • cervical neoplasms
    • cervical screening
    • psychosexual
    • service delivery
    • epidemiology

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles

    • Highlights from this issue
      British Medical Journal Publishing Group